SEC Form 4 · accession 0001131096-16-000390
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ed Park
Officer — EVP and COO
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 3, 2016 | M | 2,500 | $25.67 | A | 17,719 | D | |
| Common StockF2 | Oct 3, 2016 | S | 2,097 | $124.15 | D | 15,622 | D | |
| Common StockF3 | Oct 3, 2016 | S | 403 | $125.08 | D | 15,219 | D | |
| Common StockF4 | Oct 3, 2016 | S | 1,300 | $124.17 | D | 13,919 | D | |
| Common StockF5 | Oct 3, 2016 | S | 200 | $125.04 | D | 13,719 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $25.67 | Oct 3, 2016 | M | 2,500 | D | Jan 5, 2010 | Mar 1, 2019 | Common Stock | 2,500 | 5,000 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of June 15, 2016, in accordance with Rule 10b5-1.
- F2Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.52 to $124.45, inclusive.
- F3Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.63 to $125.56, inclusive.
- F4Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.62 to $124.46, inclusive.
- F5Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.66 to $125.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (5) in this Form 4.